Cargando…
Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders
Nicergoline is a semisynthetic ergot derivative and has a selective alpha-1A adrenergic receptor blocking property and also other additional mechanisms of actions, both in the brain and in the periphery. It is in clinical use for over three decades in over fifty countries for conditions such as cere...
Autores principales: | Saletu, Bernd, Garg, Amit, Shoeb, Ahsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163411/ https://www.ncbi.nlm.nih.gov/pubmed/25243157 http://dx.doi.org/10.1155/2014/610103 |
Ejemplares similares
-
A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline
por: Fioravanti, Mario, et al.
Publicado: (2014) -
Dihydrogen Bond in the Aminoborane Complex of a Nicergoline Intermediate
por: Čejka, Jan, et al.
Publicado: (2019) -
Role of nicergoline in corneal wound healing in diabetic rats
por: Portela, Amanda Lemos Barros Martins, et al.
Publicado: (2021) -
A clinical trial of nicergoline to prevent temporary threshold shift
por: Klamkam, Pana, et al.
Publicado: (2022) -
Cognitions in Sleep: Lucid Dreaming as an Intervention for Nightmares in Patients With Posttraumatic Stress Disorder
por: Holzinger, Brigitte, et al.
Publicado: (2020)